FDA Investigator Eva I Merced Medina
Eva I Merced Medina has inspections in 6 countries as of 06 Nov 2023. Eva I Merced Medina has collaborated with a combinined 1757 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
150
Last Inspection Date:
06 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
Taiwan,
Chile,
Viet Nam
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Agnes M Santori,
Alonso,
Ana M Rivera,
Annette Melendez,
Ariel Cruz Figueroa,
Bailey A Uetrecht,
Beira Montalvo,
Brenda Rivera,
Carlos A Medina,
Carpios,
CDR Ileana Barreto Pettit,
David J Leray,
Dayna I Martinez,
Deborah K Richardson,
Dianne R Manuel,
Eddie A Santini,
Emily J Schramm,
Enrique Galan,
Eva Merced,
Evaj Mored,
Frances L Dejesus,
Frank Flores,
Garcial,
German Rivera,
Hector J Colon Torres,
Hristu B Chepa,
Iraida Ortiz,
Israel Santiago, OCM,
Ivonne A Vicente,
Jaime E Pares,
Javier O Vega,
John P Shelton,
Jorge E Martinez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose Fpedrode Jesus,
Jose Perez Soto,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Karl D Hezel,
Kate E Jesse,
Katherine Vargas Serrano,
Laiza V Garcia,
Laura E Garcia,
Laura M Lopez,
Laurimer Kuilan Torres,
Leslie A Mendoza,
Libia M Lugo,
Lisa M Lopez,
Lizaida E Rodriguez,
Loreily Figueroa Agrinsoni,
Lourdes Andujar,
LT Luis O Rodriguez,
LT Rafael Gonzalez,
Luis A Carrion,
Luis A Martinez Larracuente,
Luis G Rivera,
Luz N Riveradecruz,
Margo C Jones,
Maria A Medina,
Maria A Ruttell,
Marian E Ramirez,
Marianela Aponte Cruz,
Maribel V Juarbe,
Maricelys Mercado,
Marilyn Santiago,
Marybeth Willis,
Medina,
Mendoza,
Michael C Lombardi,
Miguel A Martinez,
Miguel G Manzano,
Milva E Melendez,
Minerva Rogers,
Monica Cburgos Garcia,
Moraima J Ramos Valle,
Nancy Rosado,
Neisa M Alonso,
Noreen Muniz,
Pablo Feliciano,
Pearl L Gonzalez,
Pearl Lopina,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Raymond A Lyn, Jr,
Rebecca Parrilla,
Rupa Pradhan,
Sandra Carpio,
Shelly A Rios Laluz,
Sixto M Mercado Rios,
State Agency,
Thomas B Smith,
Vilmary Negron Rodriguez,
Zuleika A Pineiro Vargas
Eva I Merced Medina's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2009 | FDA 483 | Puerto Rico Beverage Inc - Form 483, 2009-09-28 |
| March, 2011 | FDA 483 | Wyeth Pharmaceuticals Company - Form 483, 2011-03-08 |
| July, 2009 | FDA 483 | Brisas del Caribe Corp. - Form 483, 2009-07-22 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more